U.S. prescription drug spending as high as $610 billion by 2021: report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/25/2026
- S&P 500 ends marginally lower as investors focus on US-Iran war
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oil gains on little sign of progress in US-Iran talks
- S&P 500 history shows strong gains across Fed hiking cycles: BCA
- JPMorgan upgrades CoreWeave on stronger compute pricing
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
- US and Iran discuss phased deal to reopen Hormuz and end US blockade, sources say
Quintiles (Q) PT Raised to $81 at Jefferies; Reiterates Hold
May 4, 2017 10:06 AM EDTJefferies raised its price target on Quintiles (NYSE: Q) to $81.00 (from $78.00) while maintaining a Hold rating. In-line revenue was helped by ~1% inorganic contribution. Organic revenue growth was 0.7% and Integrated Engagement was above expectations. Guidance now implies 2H revenue growth of 8.0% YoY, up from 0.3% in... More
